Qube Research & Technologies Ltd - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 40 filers reported holding EVELO BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$47,555
+16.0%
29,537
+50.1%
0.00%
Q3 2022$41,000
-36.9%
19,677
-36.0%
0.00%
Q2 2022$65,000
+16.1%
30,760
+191.7%
0.00%
-100.0%
Q3 2020$56,00010,5460.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Mayo Clinic 484,953$1,823,0004.61%
Flagship Pioneering Inc. 18,233,403$68,558,0003.21%
HARBOURVEST PARTNERS LLC 1,763,505$6,622,0003.20%
Alphabet Inc. 1,060,495$3,982,0000.26%
Larson Financial Group LLC 20,042$75,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,500$501,0000.01%
CREDIT SUISSE AG/ 1,500,117$5,633,0000.01%
FMR LLC 3,220,853$12,094,0000.00%
VICTORY CAPITAL MANAGEMENT INC 177,856$668,0000.00%
Legal & General Group Plc 1,522$6,0000.00%
View complete list of EVELO BIOSCIENCES INC shareholders